Numans Health Food Holdings Company Limited(HK:2530)
HK$0.71+0.03 (+4.41%)
HK:2530
Numans Health Food Holdings Company Limited financials statements
HK$0.71
At close:+0.03 (+4.41%)
Want to see HK:2530 full AI Analyst Report?
Numans Health Food Holdings Company Limited (2530) Ratios
2 Followers
Numans Health Food Holdings Company Limited Ratios
HK:2530's free cash flow for Q2 2026 was ¥10.30M. For the 2026 fiscal year, HK:2530's free cash flow was decreased by ¥-163.56K and operating cash flow was ¥10.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 28.93 | 10.63 | 7.77 | 2.40 | 3.25 |
| Quick Ratio | 26.49 | 8.80 | 6.67 | 1.94 | 2.97 |
| Cash Ratio | 23.29 | 6.33 | 4.65 | 1.27 | 1.77 |
| Solvency Ratio | 0.54 | 2.02 | 2.74 | 0.59 | 1.43 |
| Operating Cash Flow Ratio | 2.71 | 2.24 | 2.66 | 0.29 | 1.09 |
| Short-Term Operating Cash Flow Coverage | 17.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 480.45M | ¥ 356.73M | ¥ 379.30M | ¥ 207.26M | ¥ 193.48M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.04 | 1.10 | 1.15 | 1.63 | 1.43 |
| Debt Service Coverage Ratio | -1.07 | 305.77 | 495.72 | 247.22 | 1054.34 |
| Interest Coverage Ratio | 36.51 | 426.11 | 626.94 | 327.75 | 1456.34 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | -28.32 | -2.23 | -1.28 | -1.79 | -0.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 66.57% | 76.06% | 75.22% | 74.38% | 73.04% |
| EBIT Margin | 5.17% | 35.94% | 45.71% | 26.90% | 45.69% |
| EBITDA Margin | 7.62% | 37.39% | 46.85% | 28.21% | 46.74% |
| Operating Profit Margin | 5.17% | 39.77% | 48.80% | 33.46% | 50.47% |
| Pretax Profit Margin | 12.20% | 35.84% | 45.63% | 26.79% | 45.65% |
| Net Profit Margin | 2.91% | 26.99% | 37.36% | 23.83% | 35.45% |
| Continuous Operations Profit Margin | 2.91% | 26.99% | 37.36% | 23.83% | 35.45% |
| Net Income Per EBT | 23.83% | 75.30% | 81.87% | 88.93% | 77.64% |
| EBT Per EBIT | 236.04% | 90.13% | 93.50% | 80.07% | 90.45% |
| Return on Assets (ROA) | 1.04% | 18.02% | 33.90% | 21.69% | 41.44% |
| Return on Equity (ROE) | 1.08% | 19.89% | 38.86% | 35.40% | 59.09% |
| Return on Capital Employed (ROCE) | 1.92% | 29.17% | 50.34% | 48.79% | 84.05% |
| Return on Invested Capital (ROIC) | 0.46% | 21.82% | 40.97% | 42.92% | 64.93% |
| Return on Tangible Assets | 1.05% | 18.20% | 34.20% | 21.91% | 41.44% |
| Earnings Yield | 0.97% | 11.56% | 25.49% | 14.37% | 21.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.52 | 4.04 | 5.93 | 7.29 | 5.44 |
| Payables Turnover | 124.51 | 0.00 | 0.00 | 111.63 | 0.00 |
| Inventory Turnover | 1.46 | 0.98 | 1.70 | 1.36 | 3.72 |
| Fixed Asset Turnover | 25.37 | 31.76 | 43.41 | 28.91 | 48.04 |
| Asset Turnover | 0.36 | 0.67 | 0.91 | 0.91 | 1.17 |
| Working Capital Turnover Ratio | 0.44 | 0.75 | 1.43 | 1.81 | 0.00 |
| Cash Conversion Cycle | 350.19 | 464.55 | 276.68 | 315.82 | 165.28 |
| Days of Sales Outstanding | 103.56 | 90.45 | 61.51 | 50.05 | 67.15 |
| Days of Inventory Outstanding | 249.56 | 374.10 | 215.17 | 269.03 | 98.13 |
| Days of Payables Outstanding | 2.93 | 0.00 | 0.00 | 3.27 | 0.00 |
| Operating Cycle | 353.12 | 464.55 | 276.68 | 319.09 | 165.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.05 | 0.08 | 0.15 | 0.04 | 0.09 |
| Free Cash Flow Per Share | 0.05 | 0.08 | 0.15 | 0.04 | 0.09 |
| Dividend Paid and CapEx Coverage Ratio | 0.96 | 0.75 | 1.87 | 4.49 | 3.36 |
| Capital Expenditure Coverage Ratio | 1262.86 | 73.93 | 244.83 | 9.07 | 94.37 |
| Operating Cash Flow Coverage Ratio | 12.40 | 18.84 | 25.83 | 5.95 | 76.60 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.30 | 0.35 | 0.12 | 0.28 |
| Free Cash Flow Yield | 8.45% | 12.70% | 23.98% | 6.47% | 16.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 103.13 | 8.65 | 3.92 | 6.96 | 4.70 |
| Price-to-Sales (P/S) Ratio | 3.00 | 2.34 | 1.47 | 1.66 | 1.66 |
| Price-to-Book (P/B) Ratio | 1.12 | 1.72 | 1.52 | 2.46 | 2.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.84 | 7.87 | 4.17 | 15.45 | 6.04 |
| Price-to-Operating Cash Flow Ratio | 11.83 | 7.76 | 4.15 | 13.75 | 5.98 |
| Price-to-Earnings Growth (PEG) Ratio | -1.11 | -0.16 | 0.05 | -0.26 | 0.00 |
| Enterprise Value Multiple | 11.05 | 4.02 | 1.84 | 4.09 | 2.60 |
| Enterprise Value | 155.19M | 416.66M | 368.48M | 423.88M | 410.51M |
| EV to EBITDA | 11.05 | 4.02 | 1.84 | 4.09 | 2.60 |
| EV to Sales | 0.84 | 1.50 | 0.86 | 1.15 | 1.22 |
| EV to Free Cash Flow | 3.32 | 5.06 | 2.46 | 10.75 | 4.41 |
| EV to Operating Cash Flow | 3.32 | 4.99 | 2.45 | 9.57 | 4.37 |
| Tangible Book Value Per Share | 0.49 | 0.37 | 0.41 | 0.24 | 0.20 |
| Shareholders’ Equity Per Share | 0.50 | 0.38 | 0.41 | 0.25 | 0.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.76 | 0.25 | 0.18 | 0.11 | 0.22 |
| Revenue Per Share | 0.19 | 0.28 | 0.43 | 0.37 | 0.34 |
| Net Income Per Share | 0.01 | 0.07 | 0.16 | 0.09 | 0.12 |
| Tax Burden | 0.24 | 0.75 | 0.82 | 0.89 | 0.78 |
| Interest Burden | 2.36 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.51 | 0.41 | 0.06 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 8.72 | 0.84 | 0.77 | 0.45 | 0.61 |
Currency in CNY
